581-590 of 845 results for 'consumer data right'

Who's the fairest of them all? Comparative advertising amongst cosmetic competitors
Insight 15 Dec 2020

In recent proceedings before the Federal Court, Allergan was unsuccessful in its claim for infringement of its registered BOTOX trade marks against Self Care. Allergan alleged that Self Care infringed ...

Honest concurrent use: a rock-solid reminder of the importance of specific evidence
Insight 28 Aug 2020

A recent decision of the Full Court of the Federal Court has highlighted that evidence of honest concurrent use of a trade mark must relate to the specific goods or services covered by an application. It's a timely reminder about the need for care in selecting the scope of the goods and services covered by a mark. ...

Breaking news
Insight 30 Apr 2020

Two important developments have unfolded over the past week. The InIP editors report ...

Computer-implemented business methods and manner of manufacture…where do we stand?
Insight 17 Dec 2019

In Technological Resources Pty Ltd v Tettman [2019] FCA 1889, the Federal Court decisively reversed yet another Australian Patent Office (the APO) decision to reject a patent application on the basis that it was not a 'manner of manufacture'. ...

Indemnity costs and offers of compromise
Insight 19 Dec 2018

How is the Federal Court currently handling the issue of offers of compromise and indemnity costs? Lawyer Phoebe St John recaps Reckitt Benckiser v GSK Australia (No 2) to find out the latest. ...

From Budapest to Wellington – Patents for microorganisms in New Zealand
Insight 18 Apr 2019

New Zealand recently acceded to the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure (Budapest Treaty), which came into force in New Zealand on 17 March 2019. Managing Associate Tony Shaw discusses what this means for patent appli ...

What do the Swiss and artificial sweetener have to do with patents?
Insight 18 Apr 2019

The recent Federal Court decision in Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd [2019] FCA 28 deals with fascinating issues for patentees seeking to enforce Swiss-style claims against makers of bioequivalent products. ...

A grape result – exporter of copycat Penfolds wines ordered to pay
Insight 25 Jun 2019

Companies exporting wine labelled with the Chinese equivalent of Australia's famous Penfolds brand have been ordered to pay more than $350,000 in damages for trade mark infringement. ...

ESG diligence: what it is and why it's relevant
Insight 15 Nov 2021

A company's ESG credentials can have a material impact on its long-term performance and valuation. In this video, our cross-sector experts provide the real and potential ESG due diligence traps for organisations; highlight best practices for ESG diligence on investments and acquisitions; and outline some thoughts on steps to be taking once the deal is done.   ...

ASIC announces fintech licensing exemptions
Insight 19 Dec 2016

As part of its implementation of the regulatory sandbox for fintech companies ASIC is providing relief for certain fintech businesses from the obligation to hold an Australian financial services or Australian credit licence Relief may be available for up to 12 months and may be useful to businesses ...

Refine

From
To